Basic Information
Proteostasis Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing small molecule therapies for the treatment of CF and diseases caused by other abnormal protein processing. Proteostasis was founded in 2017 and is headquartered in Boston, Massachusetts, USA.
Proteostasis Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
51~100 people
January 01, 2007
info@proteostasis.com